BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pharma Journalist - ECPv6.16.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Pharma Journalist
X-ORIGINAL-URL:https://www.pharmajournalist.com
X-WR-CALDESC:Events for Pharma Journalist
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Asia/Kolkata
BEGIN:STANDARD
TZOFFSETFROM:+0530
TZOFFSETTO:+0530
TZNAME:IST
DTSTART:20170101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20181008
DTEND;VALUE=DATE:20181010
DTSTAMP:20260515T022816
CREATED:20180411T074155Z
LAST-MODIFIED:20180522T120949Z
UID:14359-1538956800-1539129599@www.pharmajournalist.com
SUMMARY:Global Biobanking Congress
DESCRIPTION:Designed to attract industry leaders and academics\, this conference will look at ways to optimize biosample management and consider the future of emerging technologies such as mobile biobanking\, digital & cloud-based sample management and automated storage & retrieval systems. Key topics will also include data protection\, data sharing\, and the importance of ethical and regulatory considerations for maximising clinical impact. The Congress will provide a forum to network\, learn\, and engage with experts and representatives from pharmaceutical companies\, leading institutions\, and recognised biobanks worldwide.
URL:https://www.pharmajournalist.com/event/global-biobanking-congress/
LOCATION:TBC\, London\, United Kingdom\, United Kingdom
ORGANIZER;CN="Global Engage":MAILTO:info@globalengage.co.uk
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20181009
DTEND;VALUE=DATE:20181011
DTSTAMP:20260515T022816
CREATED:20180717T104113Z
LAST-MODIFIED:20180717T104113Z
UID:16780-1539043200-1539215999@www.pharmajournalist.com
SUMMARY:Outsourcing in Clinical Trials DACH 2018
DESCRIPTION:We are pleased to announce that the OCT series is extending to Switzerland 2018 to bring innovative and solutions focused content to the DACH biopharmaceutical market. Spinning off from the flagship OCT Europe event this intimate audience of local players allows for focused\, lucrative learning and networking on site. \n \nThrough in-depth research conducted with local biopharma companies\, this event will deliver insight\, debate\, discussion\, presentation and opinion on high priority outsourcing\, operations and technology-based themes within the clinical trials space locally. \nKey Agenda Highlights 2018\n1) Building collaborations with external providers to guarantee the best delivery through innovation. (Gisele Tavares\, Procurement – Global Head Alliance Management and Internal Business Partner at Roche) \n2) Onstage Interview: Working to foster a reputation in clinical development to partner with large solution providers for trusted timelines and high-quality deliverables – (Dirk Weber\, Chief Medical Officer at Cellestia Biotech AG/Aurealis Pharma AG) \n3) Considerations in observational research – the importance of long-term partnerships – (Pamela Bacon\, Head of Medical Affairs Communications and Operations\, Worldwide Markets at Celgene)  \nWhy must you attend? \nOCTDACH brings recognised experts specifically in the DACH region to discuss\, collaborate and network with a variety of key service providers as well as other biopharmaceuticals from innovative and collaborative ideas to help overcome challenges. \nThis event will deliver insights\, debates\, discussions\, presentations and opinion on high priority outsourcing\, operations and technology-based themes within the clinical trial space locally. \nTo learn more about this event\, and to register online\, visit http://bit.ly/OCTDASH2018 \nContact: \nPhone – +44 (0) 207 936 6521\nEmail – brijesh.patel@arena-international.com
URL:https://www.pharmajournalist.com/event/outsourcing-in-clinical-trials-dach-2018/
LOCATION:Radisson Blu\, Zurich Airport\, Rondellstrasse\, 8058 Kloten\, CH-8058
ORGANIZER;CN="Arena International":MAILTO:brijesh.patel@arena-international.com
END:VEVENT
END:VCALENDAR